SB
Samsara BioCapital’s Sutro Biopharma STRO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.57M | Hold |
2,196,814
| – | – | 0.32% | 22 |
|
2025
Q1 | $1.43M | Hold |
2,196,814
| – | – | 0.25% | 23 |
|
2024
Q4 | $4.04M | Hold |
2,196,814
| – | – | 0.55% | 26 |
|
2024
Q3 | $7.6M | Hold |
2,196,814
| – | – | 1.46% | 18 |
|
2024
Q2 | $6.44M | Buy |
2,196,814
+521,235
| +31% | +$1.53M | 1.35% | 19 |
|
2024
Q1 | $9.47M | Hold |
1,675,579
| – | – | 1.46% | 17 |
|
2023
Q4 | $7.19M | Hold |
1,675,579
| – | – | 1.12% | 17 |
|
2023
Q3 | $5.81M | Hold |
1,675,579
| – | – | 1.78% | 15 |
|
2023
Q2 | $7.79M | Hold |
1,675,579
| – | – | 1.37% | 13 |
|
2023
Q1 | $7.74M | Hold |
1,675,579
| – | – | 1.6% | 15 |
|
2022
Q4 | $13.5M | Hold |
1,675,579
| – | – | 2.91% | 9 |
|
2022
Q3 | $9.3M | Hold |
1,675,579
| – | – | 2.17% | 11 |
|
2022
Q2 | $8.73M | Hold |
1,675,579
| – | – | 2.33% | 11 |
|
2022
Q1 | $13.8M | Hold |
1,675,579
| – | – | 3.47% | 9 |
|
2021
Q4 | $24.9M | Hold |
1,675,579
| – | – | 4.84% | 5 |
|
2021
Q3 | $31.7M | Hold |
1,675,579
| – | – | 4.97% | 6 |
|
2021
Q2 | $31.1M | Hold |
1,675,579
| – | – | 3.85% | 7 |
|
2021
Q1 | $38.1M | Hold |
1,675,579
| – | – | 7.03% | 5 |
|
2020
Q4 | $36.4K | Hold |
1,675,579
| – | – | 3.66% | 5 |
|
2020
Q3 | $16.8M | Hold |
1,675,579
| – | – | 4.7% | 6 |
|
2020
Q2 | $13M | Buy |
1,675,579
+550,000
| +49% | +$4.27M | 4.18% | 9 |
|
2020
Q1 | $11.5M | Hold |
1,125,579
| – | – | 6.61% | 6 |
|
2019
Q4 | $12.4M | Hold |
1,125,579
| – | – | 5.93% | 6 |
|
2019
Q3 | $10.2M | Hold |
1,125,579
| – | – | 6.96% | 7 |
|
2019
Q2 | $12.8M | Hold |
1,125,579
| – | – | 8.46% | 5 |
|
2019
Q1 | $12.8M | Buy |
1,125,579
+3
| +0% | +$34 | 10.08% | 5 |
|
2018
Q4 | $10.2M | Buy |
+1,125,576
| New | +$10.2M | 9.75% | 4 |
|